New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.


Journal

Current topics in medicinal chemistry
ISSN: 1873-4294
Titre abrégé: Curr Top Med Chem
Pays: United Arab Emirates
ID NLM: 101119673

Informations de publication

Date de publication:
2019
Historique:
received: 21 11 2018
revised: 31 12 2018
accepted: 07 01 2019
pubmed: 25 1 2019
medline: 25 4 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

Phenolic acids (caffeic-, ferulic and p-coumaric acid) are widely distributed in the plant kingdom and exhibit broad spectrum of biological activities, including antimicrobial activity. The goal of this paper is the synthesis of some caffeic acid derivatives selected based on computer-aided predictions and evaluate their in vitro antimicrobial properties against Gram positive and Gram negative bacteria and also a series of fungi. In silico prediction of biological activity was used to identify the most promising structures for synthesis and biological testing, and the putative mechanisms of their antimicrobial action. The designed compounds were synthesized using classical organic synthesis methods. The antimicrobial activity was studied using microdilution method. Twelve tested compounds have shown good antibacterial activity. Five out of twelve tested compounds appeared to be more active than the reference drugs ampicillin and streptomycin. Despite that all compounds exhibited good activity against all bacteria tested, the sensitivity of bacteria towards compounds in general was different. The evaluation of antifungal activity revealed that all compounds were more active than ketoconazole, while seven compounds (2, 3, 4, 5, 7, 8 and 12) appeared to be more active than bifonazole. Docking results indicate that gyrase inhibition is the putative mechanism of antibacterial action while the inhibition of 14α-demethylase may be responsible for antifungal action. Prediction of cytotoxicity by PROTOX showed that compounds are not toxic (LD50 1000-2000 mg/kg). Thirteen compounds, from which six are new ones, were synthesized, and twelve compounds were tested for antimicrobial activity. The studied compounds appeared to be promising potent and non-toxic antimicrobials, which could be considered as leads for new pharmaceutical agents.

Sections du résumé

BACKGROUND BACKGROUND
Phenolic acids (caffeic-, ferulic and p-coumaric acid) are widely distributed in the plant kingdom and exhibit broad spectrum of biological activities, including antimicrobial activity.
OBJECTIVE OBJECTIVE
The goal of this paper is the synthesis of some caffeic acid derivatives selected based on computer-aided predictions and evaluate their in vitro antimicrobial properties against Gram positive and Gram negative bacteria and also a series of fungi.
METHODS METHODS
In silico prediction of biological activity was used to identify the most promising structures for synthesis and biological testing, and the putative mechanisms of their antimicrobial action. The designed compounds were synthesized using classical organic synthesis methods. The antimicrobial activity was studied using microdilution method.
RESULTS RESULTS
Twelve tested compounds have shown good antibacterial activity. Five out of twelve tested compounds appeared to be more active than the reference drugs ampicillin and streptomycin. Despite that all compounds exhibited good activity against all bacteria tested, the sensitivity of bacteria towards compounds in general was different. The evaluation of antifungal activity revealed that all compounds were more active than ketoconazole, while seven compounds (2, 3, 4, 5, 7, 8 and 12) appeared to be more active than bifonazole. Docking results indicate that gyrase inhibition is the putative mechanism of antibacterial action while the inhibition of 14α-demethylase may be responsible for antifungal action. Prediction of cytotoxicity by PROTOX showed that compounds are not toxic (LD50 1000-2000 mg/kg).
CONCLUSION CONCLUSIONS
Thirteen compounds, from which six are new ones, were synthesized, and twelve compounds were tested for antimicrobial activity. The studied compounds appeared to be promising potent and non-toxic antimicrobials, which could be considered as leads for new pharmaceutical agents.

Identifiants

pubmed: 30674263
pii: CTMC-EPUB-96013
doi: 10.2174/1568026619666190122152957
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antifungal Agents 0
Caffeic Acids 0
caffeic acid U2S3A33KVM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

292-304

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Maia Merlani (M)

TSMU I.Kutateladze Institute of Pharmacochemistry, Tbilisi, 0159, Georgia.

Vakhtang Barbakadze (V)

TSMU I.Kutateladze Institute of Pharmacochemistry, Tbilisi, 0159, Georgia.

Lela Amiranashvili (L)

TSMU I.Kutateladze Institute of Pharmacochemistry, Tbilisi, 0159, Georgia.

Lali Gogilashvili (L)

TSMU I.Kutateladze Institute of Pharmacochemistry, Tbilisi, 0159, Georgia.

Vladimir Poroikov (V)

Institute of Biomedical Chemistry, 10 bldg, 119121, Moscow, Russian Federation.

Anthi Petrou (A)

School of Health, Faculty of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Athina Geronikaki (A)

School of Health, Faculty of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Ana Ciric (A)

Mycological Laboratory, Department of Plant Physiology, Institute for Biological Research, Sinisa Stankovic, University of Belgrade, Bulevar Despota Stefana 142, 11000, Belgrade, Serbia.

Jasmina Glamoclija (J)

Mycological Laboratory, Department of Plant Physiology, Institute for Biological Research, Sinisa Stankovic, University of Belgrade, Bulevar Despota Stefana 142, 11000, Belgrade, Serbia.

Marina Sokovic (M)

Mycological Laboratory, Department of Plant Physiology, Institute for Biological Research, Sinisa Stankovic, University of Belgrade, Bulevar Despota Stefana 142, 11000, Belgrade, Serbia.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Animals Hemiptera Insect Proteins Phylogeny Insecticides
Populus Soil Microbiology Soil Microbiota Fungi

Classifications MeSH